By Nick Lavars When Parkinson’s patients are diagnosed with the condition, there are still many unknowns around how the disease will develop and how it will impact their lives. While it is no crystal ball, a new blood test developed at Newcastle University and Cambridge University in the UK is offering hope of better patient...
By ERIC CHESS One crucial missing piece to the devastating puzzle of Alzheimer’s disease and other types of dementia is how to detect them early. Many researchers are hard at work evaluating biomarkers like levels of proteins known as beta-amyloid and tau in cerebrospinal fluid or imaging-detected changes in the brain. There might be another,...
Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three ‘clinical risks’. Atrial fibrillation is the most common heartrhythm disturbance, affecting around 1.6 million people in the UK. Those with atrial fibrillation may be aware of noticeable...
Scientists at the Wyss Institute at Harvard University and Boston Children’s Hospital have developed a cheap, sensitive, and highly accurate way of detecting protein biomarkers. The technology may very well revolutionize diagnostics, disease monitoring, and help stop the spread of infectious pathogens. The nanoswitch-linked immunosorbent assay (NLISA) has the potential to be as simple to use...
Breathalyser uses sensors to identify biomarkers linked to the flu virus The tool can indicate if the sufferer has flu or just wants a ‘duvet day’ In the future, the tool will help people be diagnosed and treasted earlier The breathalyser could also help prevent flu epidemics from spreading Is this the end of man...
